Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Metabolic Syndrome

Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial

A. Ruban; A. D. Miras; M. A. Glaysher; A. P. Goldstone; C. G. Prechtl; N. Johnson; N. Chhina; W. Al-Najim; M. Aldhwayan; N. Klimowska-Nassar; C. Smith; J. Lord; J. V. Li; L. Flores; M. Al-Lababidi; G. K. Dimitriadis; M. Patel; M. Moore; H. Chahal; A. R. A Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial Ann Surg
Insulin Resistance & Diabetes Metabolic Syndrome

Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial

H. Risstad; T. T. Søvik; M. Engström; E. T. Aasheim; M. W. Fagerland; M. F. Olsén; J. A. Kristinsson; C. W. le Roux; T. Bøhmer; K. I. Birkeland; T. Mala; T. Olbers Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial JAMA Surg
Cholesterol Insulin Resistance & Diabetes Metabolic Syndrome

Weight loss after laparoscopic adjustable gastric band and resolution of the metabolic syndrome and its components

G. J. Ooi; L. Doyle; T. Tie; J. M. Wentworth; C. Laurie; A. Earnest; M. A. Cowley; K. Sikaris; C. W. le Roux; P. R. Burton; P. E. O'Brien; W. A. Brown Weight loss after laparoscopic adjustable gastric band and resolution of the metabolic syndrome and its components Int J Obes (Lond)
Metabolic Syndrome

Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery

G. J. Ooi; A. Earnest; L. Doyle; C. Laurie; J. M. Wentworth; K. Sikaris; C. W. le Roux; P. R. Burton; P. E. O’Brien; W. A. Brown Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery Obesity Surgery
Cholesterol Metabolic Syndrome

Bariatric surgery: the indications in metabolic disease

K. J. Neff; C. W. le Roux Bariatric surgery: the indications in metabolic disease Dig Surg
Insulin Resistance & Diabetes Metabolic Syndrome

Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis

P. Mistry; V. Currie; P. Super; C. W. le Roux; A. A. Tahrani; R. Singhal Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis Clin Obes
Cholesterol Insulin Resistance & Diabetes Metabolic Syndrome

Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease

N. G. Docherty; C. W. le Roux Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease Exp Physiol
Chronic Kidney Disease Metabolic Syndrome

Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis

R. Cohen; C. W. Le Roux; S. Junqueira; R. A. Ribeiro; A. Luque Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis Obes Surg
Insulin Resistance & Diabetes Metabolic Syndrome

Lactobacillus reuteri FYNLJ109L1 Attenuating Metabolic Syndrome in Mice via Gut Microbiota Modulation and Alleviating Inflammation

B. Yang; F. Zheng; C. Stanton; R. P. Ross; J. Zhao; H. Zhang; W. Chen Lactobacillus reuteri FYNLJ109L1 Attenuating Metabolic Syndrome in Mice via Gut Microbiota Modulation and Alleviating Inflammation Foods
Metabolic Syndrome

Deletion of iRhom2 protects against diet-induced obesity by increasing thermogenesis

M. Badenes; A. Amin; I. González-García; I. Félix; E. Burbridge; M. Cavadas; F. J. Ortega; É. de Carvalho; P. Faísca; S. Carobbio; E. Seixas; D. Pedroso; A. Neves-Costa; L. F. Moita; J. M. Fernández-Real; A. Vidal-Puig; A. Domingos; M. López; C. Adrain Deletion of iRhom2 protects against diet-induced obesity by increasing thermogenesis Mol Metab
Genetics Metabolic Syndrome

Newer posts

← Previous Page1 … Page10 Page11

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI